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The “some invalid, some valid instrumental variable estimator” (sisVIVE) is
a lasso-based method for instrumental variables (IVs) regression of outcome
on an exposure. In principle, sisVIVE is robust to some of the IVs in the analy-
sis being invalid, in the sense of being related to the outcome variable through
pathways not mediated by the exposure. In this paper, we consider the applica-
tion of sisVIVE to a Mendelian randomization study in which multiple genetic
variants are used as IVs to estimate the causal effect of body mass index on
personal income in the presence of unobserved confounding. In addition to
analyzing data from the large-scale longitudinal household survey Understand-
ing Society, we conduct a simulation study to (a) assess the performance of
sisVIVE in relation to that of competing robust methods like “MR-Egger” and
“MR-Median” and (b) identify scenarios under which its absolute performance
is poor. We find that sisVIVE outperforms alternative robust methods, in terms
of mean-square error, across a wide range of scenarios, but that its performance
is poor in absolute termswhen the presence of indirect pleiotropy leads to failure
of the “InSIDE” condition, which is not explicitly required for identification.We
argue that this is because the consistency criterion for sisVIVE does not identify
the true causal effect when InSIDE fails.
KEYWORDS
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1 INTRODUCTION
The some invalid, some valid instrumental variables estimator (sisVIVE) is a variant of the lasso for instrumental variables
(IVs) regression when some of the IVs in the analysis are not valid.1 IV methods are used for Mendelian randomization
(MR) studies in epidemiology2,3 and social and economic research.4,5 These studies involve the use of genetic variants
as IVs to estimate the causal effects of modifiable exposures on outcomes from observational data. IVs can potentially
overcome the problems of unobserved confounding and reverse causation that usually affect the estimation of causal
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effects using observational data. A genetic variant is a valid IV if it is (a) associated with the exposure, (b) has no direct
effect on the outcome, and (c) has no indirect effect through the unobserved confounding variables on the outcome.
The genetic variants used in MR studies are called single-nucleotide polymorphisms (SNPs). SNPs are locations in the
DNAsequence that typically comprise a base pair of variant forms called alleles. The alleles at these locations vary between
individuals in that individuals can have zero, one or two copies of a specific allele. If the exposure being studied is the
expression (or phenotype) of a SNP, then this SNP is, potentially, a valid IV. If only one SNP is used as an IV, the causal
effect of the exposure on the outcome is estimated using the ratio of the estimated coefficient of the SNP—obtained from
the regression of the outcome on the SNP—to the corresponding coefficient from the regression of the exposure on the
SNP.6 If the SNP is a valid IV, and the causal relationship between exposure and outcome is linear, the ratio estimator will
be consistent, but not unbiased, for the true causal effect.
Awell-known problemwith ratio estimators is “weak instrument bias,” that is, the bias that arises when an IV is insuffi-
ciently predictive of the exposure.7,8 This is often true for MR studies where the correlations between SNPs and exposures
tend to be small. One strategy for avoiding weak instrument bias is, if available, to use more than one SNP. Multiple SNPs
can be combined into what are called allele, genetic or polygenic risk scores9 to be used as IVs for ratio estimation. Alter-
natively, one can use two-stage least squares (2SLS), rather than ratio estimation, with the SNPs as multiple IVs.10 In both
cases, the rationale for using multiple SNPs is that the additional information contained by these SNPs will predict the
exposure more accurately and thus alleviate weak instrument bias.
In this paper, we use MR to estimate the causal effect of body mass index (BMI) on personal income using data from
Understanding Society: the UK Longitudinal Household Study (UKHLS). UKHLS contains rich genetic data from which
we obtain 71 out of the 97 common genetic variants found to be associated with BMI in genome-wide association studies
(GWASs) at the genome-wide level of significance.11 We adopt the multiple SNPs strategy here because the single genetic
marker most strongly associated with BMI—the FTO gene (rs1558902)—explains only 0.27% of the variation.
The use of multiple SNPs presents two further challenges. The first is that, even if all the SNPs were valid IVs, the com-
bined explanatory power of the additional SNPs could still be small enough to lead tomanyweak instruments bias.12 This
is certainly possible here because combining all 97 BMI-associated SNPs from the GIANT study explains only 2.7% of the
total variation in BMI.11 A “two-sample” strategy has been proposed to alleviate this problem, that is, rather than esti-
mating the SNP-exposure associations using the analysis sample, estimates of these associations are taken from another,
ideally much larger, data set.13 Provided that the second data set was drawn from the same (or at least a comparable) pop-
ulation as the original, and the estimates were precise, this strategy would eliminate weak instrument bias. Hence, we
also consider a two-sample strategy for our analysis using estimates of the associations between the SNPs and BMI from
the GIANT consortium.11
The second, and most important, challenge facing any MR study is that some of the SNPs are not valid IVs satisfying
conditions (a) to (c) above. This is usually caused by “pleiotropic” SNPs, that is, SNPs which are related to individual
traits other than the exposure. However, there has been recent work on developing “robust” IV methods that adjust for
pleiotropic bias. Ourmainmethodological focus is thus on comparing the performance of the recently developed sisVIVE
with two established approaches, “MR-Egger” regression14 and “MR-Median” regression.15 Our objectives are twofold: to
assess the relative performance of sisVIVE in comparison with its competitors and to investigate scenarios under which
sisVIVE performs poorly in absolute terms.
2 MODELS FOR MENDELIAN RANDOMIZATION STUDIES
2.1 Choosing SNPs
A single-SNP MR study will typically involve a SNP for which there is robust evidence that it is a genotype for the
exposure. This evidence is usually obtained from a dedicated GWAS. A GWAS involves estimating the associations
between a genome-wide set of genetic variants (typically SNPs) and biological traits to identify which of these variants
are associated with each trait. GWAS are adjusted for errors due to multiple testing, potential confounders of these asso-
ciations, and for population groups with different genotype distributions (the so-called population stratification). The
genome-wide level of significance is determined statistically; a p-value significance threshold of 5 × 10−8 has become
widely accepted.
The accuracy of a GWAS in determining which SNPs are associated with a given trait depends on the sample size and,
particularly, on the adequacy of the confounding and population-stratification adjustments. However, as we have already
discussed, there is also a risk that GWAS-identified SNPs will be pleiotropic so that either condition (b) or (c) does not
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hold; this would lead to biased estimates even if the association between the SNP and exposure were not weak.16 In the
subsequent development, we distinguish between the “direct” pleiotropy that results from failure of condition (b) and the
“indirect” pleiotropy that results from failure of condition (c).
As explained above, the UKHLS contains 71 of the 97 SNPs identified by the GIANT consortium as being associated
with BMI.11 The full list of these SNPs is given in Table S1 in the Supplementary Information; the distributions of each
SNP in UKHLS and GIANT consortium are given in the Table.
2.2 Modeling assumptions
We denote the outcome variable by Y and the exposure by X, and consider scenarios in which Y can be treated as a
continuous variable that is causally related to X by the linear model
Y = 𝛾0 + 𝛾XX + 𝜖Y , (1)
where 𝛾X is the causal exposure effect, and 𝜖Y is the model error comprising the combined effect of every influence (apart
from X) on outcome Y. Any adjustments for observed confounding variables associated with exposure and outcome may
be included but, for notational simplicity, we have omitted these from (1). It is supposed either way that there remains
substantial unobserved confounding because important confounding variables have been omitted. These variables are
hence absorbed into 𝜖Y and lead to an association between 𝜖Y and X. In such cases, standard regression estimation of (1)
using ordinary least squares (OLS) or generalized least squares would be inconsistent and biased for causal parameters
like 𝛾X.
The precise interpretation of 𝛾X depends on the assumptions we make about exposure-effect heterogeneity, that is,
between-person variation in the causal effect of BMI on personal income. The estimate of 𝛾X can be interpreted as the
average causal effect of BMI on personal income if (i) the effect of BMI on personal income is the exactly the same for
everyone or,more realistically, (ii) the between-person variation in the effect of BMI among peoplewith the same observed
BMI is the same for all levels of BMI (after adjusting for the multiple SNPs); see chapter 5.2 in the work of Wooldridge.17
MR studies involve choosing one or more SNPs to use as IVs. Suppose that we use GWAS studies to identify J SNPs,
which we denote by G = (G1, … ,GJ). Each SNP takes values from {0, 1, 2} depending on the number of times that the
allele associated with increased exposure was found at this gene location. This allele is referred to as the “risk” or “effect”
allele, and the other as the “base” or “noneffect” allele. We choose the effect allele for each of the 71 SNPs to be the one
used by the GIANT consortium; see Table S1 in the Supplementary Information.
Using this notation, we can respectively rewrite conditions (a) to (c) for a single SNP, Gj, in a slightly more formal
way as follows. (i) The exposure is associated with the SNP such that E(Y |G𝑗 = g) depends nontrivially on g. (ii) No
direct pleiotropy corresponds to no direct effect of the SNP on the outcome such that E(Y |X = x,G𝑗 = g, 𝜖Y ) does not
depend on g. (iii) No indirect pleiotropy corresponds to no association between the SNP and the unobserved confounding
variables such that E(𝜖Y |G𝑗 = g) = 0. Note that conditioning on the other SNPs, and on observed confounding variables,
is suppressed. Conditions (i) to (iii) are sometimes referred to as the core conditions10; the SNP Gj is a valid IV only if it
satisfies all three core conditions.
Finally, we take the independence assumption to hold throughout the following development, that is, the multiple SNPs
are drawn from distinct gene regions such that the Gj are mutually independent at the population level.
3 ESTIMATING CAUSAL EXPOSURE EFFECTS
3.1 Estimation with multiple SNPs that are all valid IVs
The ratio estimator and two-stage least squares: If only one valid SNP, Gj, was available, then the ratio estimator
?̂?X;𝑗 = Γ̂𝑗∕b̂𝑗 (2)
would be consistent and efficient for the causal effect 𝛾X. The numerator Γ̂𝑗 is the OLS estimator of the coefficient ofGj in
the regression of Y on Gj, and the denominator b̂𝑗 is the OLS estimator of the corresponding coefficient in the regression
of X on Gj. (Note that, if covariates were also included in this analysis, Y and X in the preceding description would be
respectively replaced by the residuals obtained from regressing Y and then X on these covariates.)
The ratio estimator is a special case of 2SLS. 2SLS is consistent and normally distributed in large samples if all of the
SNPs are valid IVs satisfying the core conditions. Stage one of 2SLS for a single exposure X involves fitting a regression
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model of the form
X = zb + 𝜖X (3)
using OLS to obtain b̂, where z is a row vector of predictors comprising a constant term and the instrumental variable(s),
b is a column vector of regression coefficients, and 𝜖X is themodel residual satisfyingE(𝜖X|G)= 0. Stage two involves using
b̂ to obtain X̂ = zb̂ and then finally regressing Y on X̂ using OLS; the 2SLS estimator ?̂?2SLSX is simply the OLS estimator of
the coefficient of X̂ . Note that ?̂?2SLSX is equal to ?̂?X;𝑗 in (2) if z = (1,Gj).
To facilitate our comparison with sisVIVE further on, we write the 2SLS estimator as
?̂?2SLS = argmin
𝛄
[
{𝛆Y (𝛄)Z}WN{𝛆Y (𝛄)Z}′
]
, (4)
where ?̂?2SLS = (?̂?2SLS0 , ?̂?
2SLS
X )
′ is the 2SLS estimator of 𝛄 = (𝛾0, 𝛾X)′, Z is the design matrix of candidate IVs with row i
given by zi,WN = (Z′Z)−1 is the weight matrix, 𝛆Y(𝛄) = (𝜀Y; 1,… ,𝜀Y; N) is the row vector of residuals 𝜀Y; i = Yi − 𝛾0 − 𝛾XXi
under model (1), and zi, Xi, and Yi are respectively the observed values of the IVs, exposure, and outcome for individual
i = 1,… ,N.
There are thus two ways to incorporate multiple SNPs into an analysis.
Polygenic risk scores: The most straightforward strategy for IV analysis with multiple SNPs is to combine the SNPs to
form a polygenic risk score (also known as an allele score or genetic risk score). The ratio estimator using the polygenic
risk score as an IV can then be used to estimate 𝛾X.9 A polygenic risk score has the general form
G =
∑J
𝑗=1
w𝑗G𝑗 , (5)
where wj is a user-specified weight for SNP Gj. The simple polygenic risk score (SPRS) is obtained by setting wj = 1 for
every SNP. Alternatively, the internally weighted polygenic risk score (IPRS) can be obtained by setting w𝑗 = b̂𝑗 . In either
case, the ratio estimator with polygenic score G as the IV can be used to estimate the causal effect, or 2SLS with z = (1,G)
in (2) can equivalently be used.
Multiple IVs: An alternative to polygenic risk scores is to treat the J SNPs as multiple IVs for exposure X by setting
z = (1,G) in (2).
Bowden et al14 show that the ratio estimate based on a polygenic risk score G is a weighted sum of the ?̂?X;𝑗 , that is,
the ratio estimate obtained using SNP j as the sole IV for X; the SPRS and IPRS estimates differ in how the SNP-specific
estimates are combined. Multiple-IV 2SLS is exactly equivalent to IPRS in large samples if the independence assumption
holds, that is, the population correlations between the SNPs and exposure are all equal to zero. IPRS is the basis of the
inverse weighted (IVW) estimator for MR studies using summarized data.14,18
3.2 Estimation with multiple SNPs where some are invalid IVs using sisVIVE
If any of the chosen SNPswere invalid IVs, then every estimator discussed in Section 3.1 would be inconsistent and subject
to further bias regardless of whether or not the IVs were weak. This is because pleiotropy would lead to model (1) being
incorrectly specified. In the presence of pleiotropy, it is assumed that model (1) becomes
Y = 𝜋0 + γXX +
∑J
𝑗=1
(𝛼𝑗 + 𝜃𝑗)G𝑗 + 𝜖Y , (6)
wheremodel error 𝜖Y satisfiesE(𝜖Y|G)= 0, 𝛼j ≠ 0 if pleiotropicGj fails core condition (ii), and 𝜃j ≠ 0 if it fails core condition
(iii).14 Without any loss of generality, we shall henceforth assume that Y, X, and G are all mean centered so that 𝜋0 = 0.
Under model (6), the relationship between the true numerators and denominators of the SNP-specific ratio estimators
can be written as
Γ𝑗 = 𝜋𝑗 + γXb𝑗 , (7)
where 𝜋j = 𝛼j + 𝜃j is the sum of the pleiotropic errors related to SNP j = 1,… , J. This relationship drives the “consistency
criterion” that identifies the causal exposure effect when the identity of the invalid-IV SNPs is unknown.1
Kang et al1 developed sisVIVE (the “some invalid some valid instrumental variable estimator”) to estimate γX under
model (4) when the set of valid-IV SNPs is unknown. They first show that, while model (6) is not generally identified if
the set of valid-IV SNPs is unknown, it can be identified if over half of the SNPs are valid IVs, that is, the “majority rule.”
Constrained estimation of model (6) subject to the majority rule holding is infeasible, but the closely related problem(
?̂?X;𝜆
?̂?𝜆
)
= argmin
𝛄,𝛑
[1
2 {𝛆Y (𝛾X ,𝛑)Z}WN{𝛆Y (𝛾X ,𝝅)Z}
′ + 𝜆||𝛑||1] (8)
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is feasible. The terms of (8) are defined as follows: 𝜆 is a scalar “tuning” parameter; ||𝛑||1 = ∑J𝑗=1|𝜋𝑗| is the 𝓁1-norm;
WN is the same weight matrix as used for 2SLS (2); 𝛆Y(𝛾X,𝛑) = (𝜀Y; 1,… , 𝜀Y;N); 𝜀Y;i = Yi − 𝛾XXi − 𝛑′zi is the value of the
residuals in model (4) for individual i; and 𝛑 = (𝜋1,… ,𝜋J)′. If both core conditions (ii) and (iii) held, then Equation (8)
would reduce to 2SLS (4) because 𝛑 would equal zero.
The resulting procedure is closely related to the “lasso” a technique used to identify subsets of predictor variables with
nonzero regression coefficients.19 The idea is to constrain the sum of the absolute values of {𝜋j} so that the optimizer is
forced to shrink toward zero those 𝜋j that have least impact on the first component {𝛆Y(𝛾X,𝛑)Z}WN{𝛆Y(𝛾X,𝝅)Z}′ in (8), that
is, the valid-IV SNPs. In doing this, sisVIVE identifies the set V̂ = {𝑗 ∶ 𝜋𝑗;𝜆 = 0} as an estimate of the true set of valid-IV
SNPs V = { j : 𝜋j = 0}.
The choice of tuning parameter is crucial: a large value of 𝜆 would force 𝛑 to be heavily penalized unless it were very
close to zero, whichwould result in every SNP being classed as a valid IV; conversely, a small value of 𝜆would lead to every
SNP being treated as an invalid IV. The choice of 𝜆 is made using cross-validation to estimate the prediction error across a
range of fixed tuning-parameter values. Rather than choosing the value 𝜆= 𝜆min thatminimizes the cross-validation error,
𝜆min is incremented by a value determined by the “one standard error” rule (the standard error being that of the average
prediction errors across the different cross-validation samples) in order to reduce the chance of incorrectly identifying
invalid-IV SNPs as valid IVs.1,19 This last point is important because incorrectly treating invalid-IV SNPs as valid IVs has
been shown to lead to greater bias than incorrectly identifying valid-IV SNPs as invalid-IV ones.1
Belloni andChernozhukov20 have shown that the shrinkage induced by standard lasso estimators exacerbates the bias of
themodel-parameter estimate and that sisVIVE ismore effective at identifying the set of valid-IV SNPs,V, than estimating
𝛑 and 𝛾X. They hence proposed the use of “post-lasso” estimators to reduce this bias. In the same spirit, Windmeijer et al21
considered post-lasso estimators for sisVIVE in which only the SNPs identified as valid IVs in V̂ are used as multiple IVs
in 2SLS; they found the resulting estimator to be subject to considerably lower bias than sisVIVE. However, they also
derive theoretical results that show that sisVIVE is not always consistent, in the sense that V̂ ↛ V as n→∞: in short, if
the relative strengths of the valid-IV and invalid-IV SNPs do not satisfy the “irrepresentable condition,”22 then sisVIVE
will not be consistent and can perform poorly.
Finally, we make the following note about sisVIVE in the presence of heterogeneous causal effects. In Section 2.2, it
was noted for 2SLS that 𝛾X can be interpreted as the average causal effect if the effect of BMI is homogenous, or there is
heterogeneity but the between-individual variation in BMI effects is independent of the exposure given the genetic IVs.
Kang et al1 stated that the same assumptions are required if wewish to interpret 𝛾X as the average causal effect when using
sisVIVE. However, we show that a further constraint is required if model (6) holds because the potential dependence of
the mean treatment effect on the SNPs can result in 𝜋j ≠ 0 even if SNP j is a valid IV, that is, the between-individual
variation in BMI causal effects ismean independent of both exposure and the SNPs (see Section S2.1 in the Supplementary
Information).
We now briefly outline the two established robust methods to be compared with sisVIVE.
MR-Egger regression: Bowden et al14 developed MR-Egger by adapting the Egger regression technique from the meta-
analysis literature to MR. MR-Egger involves treating estimates {Γ̂𝑗 , b̂𝑗 ∶ 𝑗 = 1, … , J} as data when fitting the simple
linear regression
Γ̂𝑗 = γEgg0 + γ
Egg
X b̂𝑗 + 𝜖
Egg
𝑗
, (9)
where 𝜖Egg
𝑗
is a residual assumed to satisfy E(𝜖Egg
𝑗
||b𝑗 ) = 0 (noting that expectation here is with respect to the set of chosen
SNPs). Model (9) can be fitted using the inverse of the estimated residual variance from the regression of Y on SNP j as
weights to account for differential minor allele frequencies (MAFs) such that SNPs with lowMAFs contribute little to the
estimation of (9).
The requirement that E(𝜖Egg
𝑗
||b𝑗 ) = 0 is called the “InSIDE” condition.14 If InSIDE holds, then γEggX = 𝛾X and the true
intercept term γEgg0 = E(𝜋𝑗) is such that γ
Egg
0 = 0 if the SNPs are all valid IVs. InSIDE is thought to be plausible if core
condition (ii) fails but is generally unrealistic if condition (iii) fails because failure leads to both bj and 𝜖Egg𝑗 depending on
𝜃j.14 MR-Egger also requires that b̂𝑗 is precisely estimated because otherwise γEggX will be biased toward zero (see also the
discussion of the “no measurement error assumption” in Section 3.3).
MR-Median: Bowden et al15 proposed MR-Median as an alternative to MR-Egger that, in theory, does not require the
InSIDE condition to hold. The authors view MR-Median as a practicable alternative to the sisVIVE estimator to be intro-
duced next. Themain strengths ofMR-Median are its simplicity and that it can be used if only summary data are available.
It is simply the median of the SNP-specific ratio estimates; in other words, letting {?̂?X( 𝑗) ∶ 𝑗 = 1, … , J} be the ordered
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set of SNP-specific ratio estimates (ie, such that ?̂?X(𝑗+1) ≥ ?̂?X(𝑗) for all j = 1, … , J − 1), then γ̂MedX = ?̂?X(J∕2) if J is even and
γ̂MedX = {?̂?X(J∕2) + ?̂?X(J∕2+1)}∕2 if J is odd. MR-Median is consistent for 𝛾X if the majority rule holds, that is, less than J/2, or
50%, of the SNPs are invalid IVs but can be biased and does not converge in distribution to a normal random variable.
3.3 Two-sample strategies
In the discussion so far, it has been assumed that the analysis will be based on one individual-level data set. It is, however,
possible to adopt a two-sample strategy if estimates of the SNP-exposure associations are available fromanother, preferably
much larger, study.23-25 We denote the estimates obtained from this second sample by {b̃𝑗 ∶ 𝑗 = 1, … , J}.
Estimates from a second sample can be incorporated into the approaches described above as follows.
• Externally weighted polygenic risk score (EPRS): choose w𝑗 = 𝛽𝑗 in (5) and denote the resulting estimate by ?̂?EPRS.
• 2SLS: Use X̃ = z′𝛃 in stage two rather than X̂ .
• MR-Egger: Fit Γ̂𝑗 = γEgg0 + γ
Egg
X b̃𝑗 + 𝜖
Egg
𝑗
rather than (9).
• MR-Median: The median of
{
̂̃𝛾X(𝑗) ∶ 𝑗 = 1, … , J
}
, where ̂̃𝛾X;𝑗 = Γ̂𝑗∕b̃𝑗 .
• sisVIVE: Use 𝜀Y ;i = Yi − γXX̃i − 𝛑′zi, where X̃i = z′i b̃, and apply (8).
In terms of estimator performance, the impact of the usual weak instrument bias is ameliorated using ̂̃𝛾X;𝑗 = Γ̂𝑗∕b̃𝑗 rather
than ?̂?X;𝑗 because, in contrast to b̂𝑗 and Γ̂𝑗 , there is no association between b̃𝑗 and Γ̂𝑗 (or this association is very weak if the
two samples have some individuals in common)13; in fact, if b̃𝑗 = b𝑗 , then ̂̃𝛾𝑗 would be unbiased because it would reduce
to an OLS estimate from the regression of Y on the known and unconfounded variable Gjbj. More realistically, we require
the standard error of b̃𝑗 to be small, and both samples to be drawn from the same population (or at least, from two different
but homogeneous populations), for b̃𝑗 ≃ b𝑗 to hold.26,27 Such scenarios satisfy what is called the no measurement error
(NOME) condition.13 However, if b̃𝑗 is not precisely estimated, then NOME will not hold. NOME is so-called because the
imprecision means that b̃𝑗 = b𝑗 + 𝜇𝑗 , where 𝜇j behaves like mean-zero measurement error; the estimate is hence subject
to an attenuation bias toward zero if NOME fails. This second form of weak-instrument bias can be viewed as a kind of
conservative shrinkage, which is less harmful than the first because it makes it more difficult to reject the null hypothesis
of no causal effect.
3.4 Nonlinear exposure effects
The development above focuses on linearmodels with linear exposure effects. If the true exposure effect is nonlinear, with
a curvilinear or piecewise-linear form, then the ratio estimator is no longer consistent for the average causal effect. In the
valid-IV case, 2SLS needs only a smallmodification to remain consistent: the first stage is unchangedwith only the second
stage requiring modification to match the nonlinear form of the exposure effect. If the effect of X is piecewise nonlinear,
such that the exposure is replaced by dummy variables representing the interval in which the observed exposure lies,
identification typically requires at least as many IVs as there are piecewise intervals.
The robust methods considered here are all built around model (1) with a single-parameter linear exposure effect. Nei-
ther MR-Egger nor MR-Median can be straightforwardly used because both hinge on the ratio estimator, which derives
from the linear structural model (1). sisVIVE is based around constrained 2SLS estimation and so, in principle, can be
adapted to nonlinear exposure effects. However, care must be taken to establish identification because the results
underpinning sisVIVE are all based on the single-SNP ratio estimates.1
4 ANALYSIS USING UKHLS DATA
MRhas been used recently to understand themechanismof relationship of highBMI and disadvantage of social-economic
status, such as low income: Tyrrell et al28 used highly self-selected UK Biobank data for their analysis, where income is
reported at the household level, and Böckerman et al29 used a small sample for their analysis, which severely limits the
power of that study; we refer the reader to these articles for a justification for the existence of a linear effect of BMI on
income.We apply themethods introduced above to the larger andmore representativeUKHLS sample data to estimate the
causal effect of BMI onpersonal income. For ourmultiple SNPs,weuse 71 out of the 97 commongenetic variants identified
as being associated with BMI at a genome-wide level of significance.11 The 16 excluded SNPs were either obtained from
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analyses involving only men, only women, or including non-Europeans (6 SNPs), or based on imputed data found to
be below the 0.9 threshold (10 SNPs).11 The remaining 71 variants explain 1.6% of the variation in BMI among UKHLS
participants; the effect-allele frequencies from both UKHLS and the GIANT consortium11 are listed in Supplementary
Information Table S1.
UKHLS is an annual household-based panel study that started collecting information about the social, economic, and
health status of its participants in 2009. The data set used for our analysis is drawn from the General Population Sample
(GPS) and the British Household Panel Survey (BHPS) arms of UKHLS (BHPSmerged with wave two of UKHLS in 2010).
UKHLS collected additional health information, including BMI and blood samples, at wave two (for GPS members) and
wave three (for BHPS members). A total of 10 480 individuals were genotyped using the Infinium Human Core Exome
Beadchip. After quality-control steps, a sample of 9944 individuals was obtained from which a further 1104 individuals
were excluded using the following criteria: genetic relatedness larger than 0.05% (N = 707); BMI greater than 60 kg/m2
(N = 8); and aged under 25 (N = 389). The number of cases with at least one wave of personal income and no missing
values of BMI, SNPs and covariates is N = 8047.
The outcome is average annual personal income (API) for each individual taken over three consecutive waves start-
ing from the wave at which the individual's health information was recorded. For individuals with one or two of these
observations missing, we took the mean API over the available waves. We standardized both BMI and API, where API
was standardized separately for the GPS and BHPS samples because mean API is higher in the BHPS than in GPS. To
control for population stratification, we restricted our analysis to the white population and included the following base-
line covariates C: age (at which BMI was measured), gender, and the first 20 genetic principal components to control for
ancestry.27
We do not consider nonlinear effects of BMI in this analysis. Our preliminary analyses did not detect any nonlinear
effects of BMI on income, using the semiparametric method proposed by Stanley and Burgess,30 so we are able to focus
on the linear-exposure case and compare the performance of the three robust methods discussed above.
To obtain covariate-adjusted estimates of the causal effect, we do not work with raw API and raw BMI but adjusted
API and adjusted BMI. Each adjusted variable is equal to the fitted residual obtained from regressing it on C. For the
two-sample strategy, the exposure-SNP estimates {b̃𝑗} come from the GIANT study11 and so are already adjusted for C.
The scatter plots of association of SNP-BMI against associations of SNP-Income for 71 SNPs based on one-sample and
two-sample strategies are given in Figure 1.
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FIGURE 1 Scatterplot of SNP-BMI association against SNP-Income association of 71 SNPs under one-sample and two-sample strategies.
Under one-sample (left), both SNP-BMI and SNP-Income associations are from UKHLS, under two-sample (right), SNP-BMI associations are
from GWAS study. BMI, body mass index; GWAS, genomewide association study; SNP, single-nucleotide polymorphism; UKHLS,
Understanding Society: the UK Longitudinal Household Study [Colour figure can be viewed at wileyonlinelibrary.com]
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TABLE 1 Estimates of the effect of BMI on personal income using n = 8047
cases from the UK Household Longitudinal Study
Estimate Std. Error P-value
Observational association −0.032 0.011 0.002***
One-sample strategy
SPRS −0.112 0.082 0.173
IPRS −0.049 0.066 0.458
2SLS −0.048 0.064 0.449
LIML −0.058 0.081 0.470
Weighted MR-Egger −0.126 0.115 0.272
Egger test 0.003 0.004 0.411
Weighted MR-Median −0.137 0.097 0.157
sisVIVE −0.048 - -
Number of invalid IVs detected by sisVIVE 0
Two-sample strategy
EPRS −0.155 0.076 0.041**
2SLS −0.154 0.071 0.030**
Weighted MR-Egger −0.311 0.179 0.082*
Egger test 0.005 0.005 0.302
Weighted MR-Median −0.292 0.106 0.006***
sisVIVE −0.141 - -
No. invalid IVs detected by sisVIVE 0
Abbreviations: BMI, body mass index; EPRS, externally weighted polygenic risk score;
IPRS, internallyweighted polygenic risk score; IVs, instrumental variables; LIML, limited infor-
mation maximum likelihood; MR, Mendelian randomization; sisVIVE, some invalid, some
valid instrumental variable estimator; SPRS, simple polygenic risk score; 2SLS, two-stage least
squares.
It can be seen from Table 1 that the potentially confounded association between personal income and BMI has a signifi-
cant negative value. Interpreting this estimate causally, we estimate that a one standard-deviation increase in BMI (that is,
of 5.26 BMI points) is estimated to lead on average to a decline in personal income of −0.032 of a standard deviation
(£431.20).
Perhaps surprisingly, sisVIVE did not identify any invalid IVs. This is the case using both one-sample and two-sample
strategies, and despite sisVIVE using the one-standard-error rule to choose the tuning parameter, which typically
incorrectly identifies valid-IV SNPs as invalid IVs.
We thus conclude that the valid-IV methods discussed in Section 3.1 can be used in conjunction with all 71 SNPs to
estimate the causal effect of BMI on personal income. The first pair of one-sample results are ratio estimates obtained
using for the SPRS and IPRS as IVs. The next two results use 2SLS and limited information maximum likelihood (LIML)
treating the 71 SNPs asmultiple distinct IVs. As expected, IRLS andmultiple-IV 2SLS give very similar results because the
71 SNPs are drawn from different gene regions and hence mutually independent. All four estimates are larger (negative)
than the observational association but are also nonsignificant.
Because sisVIVE detects no invalid-IV SNPs, the valid-IV results above can also be classed as post-sisVIVE estimates.
We would reach the same conclusion using the other robust methods: the MR-Egger test (for a nonzero intercept term)
was not significant, and neither the MR-Egger nor MR-Median estimates were statistically significant (noting that the
large standard errors indicate that both are less powerful than the valid-IV methods when there are no invalid IVs).
Using a two-sample strategy, we find no evidence for any invalid-IVs SNPs but, in contrast to the one-sample results,
find a statistically significant large negative causal effect of BMI on personal income. The significance is, to a large extent,
a consequence of estimated effect sizes that are larger than for any of the one-sample results. Note also the following
points: as expected, the EPRS and two-sample version of multiple-IV 2SLS produce very similar estimates because the
71 SNPs satisfy the independence assumption; and we do not present two-sample LIML results because this estimator
is used solely to reduce the impact of many weak instruments bias, which is not an issue for two-sample strategies. The
robust estimates obtained usingMR-Egger andMR-Median are again far larger (negative) than the post-sisVIVE ones but
are statistically significant despite estimated less precisely.
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The interpretation of these findings hinges crucially on the following untestable assumptions: the two-sample approach
requires that the data in the GIANT study and UKHLS are drawn from homogeneous populations; MR-Median and
sisVIVE both require that the total number of invalid-IV SNPs does not exceed 35; andMR-Egger requires that the InSIDE
condition holds, that is, there is no relationship between the strength of SNP-BMI association and the size of its pleiotropic
effect on personal income in model (6). It is not possible to definitively resolve which of these assumptions holds, but
in the next section, we conduct a simulation study to investigate more generally the relative performance of sisVIVE
compared with other methods, for different numbers of invalid-IV SNPs increases and different types of pleiotropy.
5 SIMULATION STUDY
We now carry out a simulation study to compare the effectiveness of sisVIVE with that of the other robust methods
introduced above. The basic design of the study is based on those reported by Kang et al1 and Bowden et al,14 but here
the data are simulated to mimic key characteristics of the UKHLS. Furthermore, the comparison is not just with 2SLS but
with other robust methods.
We now set up a simulation study to investigate the following questions raised by the preceding development and data
analysis:
A. How accurately does sisVIVE identify valid-IV SNPs and how is this accuracy affected as the number of valid-IV SNPs
increases?
B. Post-sisVIVE estimators involve using sisVIVE to identify the valid-IV SNPs and then applying a valid-IV estimator:
in such cases, is 2SLS the best post-sisVIVE estimator?
C. Does the best post-sisVIVE estimator perform better than MR-Egger and MR-Median in terms of estimator accuracy
and confidence interval coverage?
D. How well do post-sisVIVE estimators perform in an absolute sense? Under which scenarios is its performance
particularly good or particularly bad?
A final question, cutting across A to D, is the extent to which these answers depend on whether a one-sample or
two-sample strategy is used.
A full description of the study design is given the Supplementary Information (Section S1) but we highlight some
of its features here. The 71 SNPs G1, … , G71 are generated independently from a trinomial distribution in which the
probabilities of Gj being 0, 1, and 2 are respectively equal to the proportions of Gj being 0, 1, and 2 in the UKHLS data
(see Table S1 in the Supplementary Information). The causal association between BMI and SNP j is denoted by 𝛽 j and set
to the value taken from the GIANT consortium study.11 In the one-sample context, these are weak instruments because
the average F-statistic of the SNPs with respect to exposure BMI is 2.5 < 10. The true value of the causal effect of BMI on
income is 𝛾X = −0.2. The results presented below are all based on 1000 generated samples of size N = 10 000.
To simulate data subject to unobserved confounding, the error terms in personal-income model (1) and BMI model (3)
are respectively decomposed as 𝜖Y = U𝛾U + ?̇?Y and 𝜖X = U + ?̇?X , where U is a zero-mean variable representing the unob-
served confounding, and ?̇?Y and ?̇?X are not only mutually independent but jointly independent of (Y,X,G,U). Parameter
𝛾U = 1 controls the impact of unobserved confounding, that is, the strength and sign of the correlation between 𝜖Y and 𝜖X,
such that there is no unobserved confounding if 𝛾U = 0. Values of the outcome and exposure are respectively generated
under model (1) and model (3), with U, ?̇?X and ?̇?Y all independently generated from the standard normal distribution.
To generate pleiotropic SNPs, personal-income outcomes are generated undermodel (6) under three different pleiotropy
scenarios:
Scenario 1: Balanced direct pleiotropy where the InSIDE condition holds: 𝜃j = 0 for all j = 1, … , J but 𝛼s∼U(−0.2,0.2)
(whereU(a, b) indicates the continuous uniform distribution on real interval (a, b)) for SNPs s = 1, … , S≤ J/2, and 𝛼j = 0
for j= S+ 1, … , J. Under this scenario, individual SNPs are pleiotropic but the (externally weighted) polygenic risk score
is not because E
(∑S
s=1 𝛼s
)
= 0. The true SNP-exposure association is equal to the causal effect of the SNP: bj = 𝛽 j.
Scenario 2: As Scenario 1 (including that 𝜃j = 0 for all SNPs j = 1, … , J, and bj = 𝛽 j), except that the direct pleiotropy
is now unbalanced because 𝛼s∼U(0,0.2) and E
(∑S
s=1 𝛼s
)
> 0 for the pleiotropic/invalid-IV SNPs.
Scenario 3:As Scenario 2, except that the pleiotropic SNPs are also indirectly pleiotropic with positive 𝜃s∼U(0,0.4). The
InSIDE assumption necessarily fails in this scenario because the true association between Gs and exposure is bs = 𝛽s + 𝜃s
rather than 𝛽s (in contrast, for the valid-IV SNPs, bj = 𝛽 j) and so related to the pleiotropic effect.
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TABLE 2 Mean FSI% and FSO% of sisVIVE for 1000 simulation data sets
One Sample Two Sample
True: Precise: Imprecise:
b̃j = 𝜷 j b̃j ∼ N
(
𝜷 j, 𝟎.𝟎𝟏𝟐
)
b̃j ∼ N
(
𝜷 j, 𝟎.𝟎𝟓𝟐
)
Scenarios No. IVs MFSI MFSO MFSI MFSO MFSI MFSO MFSI MFSO
Invalid (%) (%) (%) (%) (%) (%) (%) (%)
All IVs are valid 0 - 6.9 - 0 - 0 - 0.42
InSIDE holds and 10 30.1 2.9 29.9 1.7 30.3 1.8 30.0 2.1
Direct Pleiotropy 20 20.6 9.2 21.2 6.8 21.3 6.7 20.8 7.9
(balanced) 30 17.0 13.3 17.3 13.3 17.2 13.4 17.3 14.7
InSIDE holds and 10 36.1 1.9 30.5 2.4 31.0 2.2 31.6 2.2
Direct Pleiotropy 20 25.3 12.8 24.9 13.0 24.8 12.5 23.7 8.9
(positive) 30 21.2 31.9 23.3 32.3 23.0 30.4 21.0 18.6
InSIDE fails and 10 31.9 41.3 35.7 42.7 34.4 43.9 10.6 40.8
Direct Pleiotropy 20 39.2 42.1 32.5 54.2 32.6 54.2 23.1 66.3
(positive) 30 37.6 44.5 29.5 59.5 29.1 59.3 22.4 70.6
Abbreviations: IVs, instrumental variables; FSI, False Select In; FSO, False Select Out; MFSI, mean FSI; MFSO, mean FSO;
sisVIVE, some invalid, some valid instrumental variable estimator.
For each of these scenarios, the performance of the estimators is assessed for S = 10, 20, and 30 invalid IVs, which
respectively correspond to 14%, 28%, and 42% of the SNPs; these scenarios all satisfy the requirement that less than 50%
of the SNPs are invalid.
For the two-sample strategy, we consider three levels of accuracy for the estimates from the consortium study. The
first accuracy level (“True”) is the gold standard in which b̃𝑗 is taken to equal the true association bj. The second
level (“Precise”) has the association estimated with high accuracy b̃𝑗 ∼ N
(
b𝑗 , 0.012
)
. The third level (“Imprecise”) has
b̃𝑗 ∼ N
(
b𝑗 , 0.052
)
to represent situations where the consortium study yields noisy estimates. The precise and imprecise
accuracy levels reflect degrees of failure of the NOME condition.13
Finally, the following Stata functions are used to implement the methods described above: ivreg2 to implement
SPRS, EPRS, multiple-IV 2SLS, and LIML; mregger from the mrrobust package to implement MR-Egger regression;
mrmedian from the mrrobust package for MR-Median. The R package sisVIVE (downloaded from CRAN at https://
cran.r-project.org/web/packages/sisVIVE.html) is used for sisVIVE.
QuestionA: Selecting valid-IV SNPs:We first assess the performance of sisVIVE in terms of False Select In (FSI) and False
Select Out (FSO). For each simulated data set, FSI is the ratio of the number of pleiotropic SNPs incorrectly identified as
valid IVs to the total number of pleiotropic SNPs; and FSO is the ratio of valid-IV SNPs incorrectly identified as invalid
IVs to the total number of valid-IV SNPs. The results that are shown in Table 2 are the mean FSI and mean FSO cross
1000 simulated data sets for each of the pleiotropy scenarios defined above.
Starting with FSO, when the number of pleiotropic SNPs is 30, sisVIVE incorrectly identifies (on average) up to 71% of
the valid-IV SNPs as invalid IVs, but it performswell (nomore than 5% of valid-IV SNPs incorrectly identified) when there
are only 10 pleiotropic SNPs. The deterioration in FSO as the number of pleiotropic SNPs increases is apparent under
both direct pleiotropy scenarios (Scenarios 1 and 2) for both one- and two-sample strategies. The deterioration is also
apparent under Scenario 3 (direct and indirect pleiotropy) but FSO exceeds 40% even if there are only 10 pleiotropic SNPs.
The performance of sisVIVE in terms of FSO using a two-sample strategy and using a one-sample strategy are generally
similar, except under the direct pleiotropy scenarios when the accuracy level of the SNP-BMI associations is imprecise;
in this case, failure of the NOME condition appears to prevent valid-IV SNPs being incorrectly classed as invalid IVs.
In terms of FSI, between 39% and 11% of the invalid-IV SNPs are incorrectly identified as valid IVs under the scenarios
we consider. Superficially, sisVIVE performs best in terms of FSI for two-sample strategies under Scenario 3 (direct and
indirect pleiotropy) when the accuracy level of the SNP-BMI associations is imprecise, but this is counteracted by its FSO
performance being the worst among all the scenarios.
Question B: Post-sisVIVE estimators: To assess the performance of alternative post-sisVIVE estimators, we consider the
“oracle” properties of the different valid-IV estimators from Section 3.1 (and the two-sample equivalents of these estima-
tors in Section 3.3). In other words, we assess howwell each valid-IV estimator performs when the actual identities of the
valid-IV SNPs are known. The results are presented in the Supplementary Information (Table S2).
In summary, we found that the one-sample versions of the valid-IV estimators, except for SPRS and LIML, were
adversely affected by many weak instruments bias.12 SPRS outperformed IPRS in terms of bias and MSE, despite IPRS
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TABLE 3 Simulation results for multiple instruments when 10 SNPs are invalid,
U∼N(0, 1), 𝜀Xi ∼N(0, 1), 𝜀Yi ∼N(0, 1), MC step = 1000, and sample size = 10,000
(A)
10 Pleiotropic SNPs
(Positive Direct Pleiotropy, InSIDE Holds)
True value −0.2
Mean (SD) Mean SE MSE Coverage, % Power, %
One-sample strategy
SPRS 0.342 (0.145) 0.092 0.315 9.0 86.4
IPRS 0.270 (0.124) 0.150 0.236 7.0 42.5
Weighted Egger 0.199 (0.258) 0.257 0.225 64.8 13.3
Weighted Median 0.076 (0.110) 0.114 0.088 30.6 9.2
sisVIVE-SPRS −0.106 (0.115) 0.106 0.022 81.2 15.1
sisVIVE-IPRS 0.042 (0.083) 0.078 0.065 14.5 11.6
Two-sample strategy, True precision b̃j = 𝜷 j
EPRS 0.251 (0.136) 0.084 0.222 2.0 75.4
2SLS 0.255 (0.139) 0.192 0.226 24.7 15.3
Weighted Egger −0.214 (0.483) 0.473 0.233 93.7 6.4
Weighted Median −0.099 (0.154) 0.152 0.034 90.3 10.6
sisVIVE-SPRS −0.130 (0.118) 0.108 0.019 85.3 20.0
sisVIVE-2SLS −0.128 (0.109) 0.096 0.017 84.2 29.5
(B)
10 Pleiotropic SNPs
(Positive Direct and Indirect Pleiotropy, InSIDE Fails)
Mean (SD) Mean SE MSE Coverage, % Power, %
One-sample strategy
SPRS 0.574 (0.079) 0.047 0.606 0 100
IPRS 0.938 (0.078) 0.056 1.301 0 100
Weighted Egger 1.093 (0.097) 0.061 1.682 0 100
Weighted Median 0.998 (0.115) 0.065 1.449 0 100
sisVIVE-SPRS 0.517 (0.145) 0.115 0.535 2.3 91.5
sisVIVE-IPRS 0.761 (0.140) 0.058 0.944 0.1 99.4
Two-sample strategy, True precision b̃j = 𝜷 j
EPRS 0.968 (0.080) 0.031 1.371 0 100
2SLS 0.970 (0.079) 0.057 1.376 0 100
Weighted Egger 1.149 (0.104) 0.057 1.830 0 100
Weighted Median 1.016 (0.116) 0.066 1.492 0 100
sisVIVE-SPRS 0.550 (0.149) 0.077 0.585 0.1 98.8
sisVIVE-2SLS 0.814 (0.133) 0.051 1.062 0 99.7
Abbreviations: EPRS, externally weighted polygenic risk score; IPRS, internally weighted polygenic risk
score; SD, standard deviation; SE, standard error; sisVIVE, some invalid, some valid instrumental variable
estimator; SPRS, simple polygenic risk score; 2SLS, two-stage least squares.
having smaller standard errors. Only SPRS and LIML offer close-to-nominal coverage and were the most powerful at
detecting the true causal effects. Using a two-sample strategy, every estimator was nearly unbiased for the true and precise
accuracy scenarios, but everymethod was found to be biased toward zero under the imprecise accuracy scenario, with the
consequent impact on coverage and power. The exception was EPRS for which bias was less affected by the failure of the
NOME condition than the other estimators, but its standard error was inflated leading to a highMSE and very low power.
We hence prefer SPRS as the post-sisVIVE estimator when using a one-sample strategy, and EPRS when using a
two-sample strategy. We also, however, present results from 2SLS in both cases for the purposes of comparison.
Question C: Do the best post-sisVIVE estimators perform better than MR-Egger and MR-Median? Table 3 contains the
results for scenarios with 10 invalid-IV SNPs using one- and two-sample strategies. Table 3a contains those results under
pleiotropy Scenario 2 (unbalanced direct pleiotropy where InSIDE holds) and Table 3b those under Scenario 3 (indirect
and unbalanced direct pleiotropy where InSIDE fails). For the one-sample strategy, results are presented for MR-Egger,
MR-Median, post-sisVIVE SPRS, and post-sisVIVE 2SLS. For the two-sample strategy, results are presented forMR-Egger,
MR-Median, post-sisVIVE EPRS, and post-sisVIVE 2SLS at the true accuracy level for the consortium estimates. The full
set of results across all three pleiotropy scenarios for 10, 20, and 30 invalid IVs are presented in Tables S3 to S11 in the
Supplementary Information.
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The picture that emerges from these results is that, across these scenarios, sisVIVE SPRS has the best performance in
terms of bias and MSE, closely followed by sisVIVE-2SLS. If InSIDE holds, then MR-Egger performs best in terms of bias
and confidence interval coverage using a two-sample strategy, but it performs considerably less well than post-sisVIVE
SPRS and 2SLS in terms of mean-square error; this is also the case under the precise and imprecise accuracy levels (see
Tables S6-S8 in the Supplementary Information). The poor performance of MR-Egger under the one-sample strategy is
thus explained by the impact of many weak instruments bias.
Question D: How well does sisVIVE do in an absolute sense? It is clear that, across all the scenarios, the post-sisVIVE
estimators are subject to substantial bias and that these biases are very large if (a) a one-sample strategy is used (in all
circumstances apart from the less plausible Scenario 1) and (b) Scenario 3 holds (where InSIDE fails due to the pres-
ence indirect pleiotropy). This conclusion holds if performance is also judged in terms of coverage and power of the
normal-based confidence intervals.
Overall, the same patterns are found for scenarioswith 20 (see Tables S4, S7, and S10 in the Supplementary Information)
and 30 (see Tables S5, S8, and S11) invalid-IV SNPs, except that the magnitude of the biases and MSEs, and the extent
to which the confidence intervals fail to achieve nominal coverage, becomes worse as the number of invalid-IV SNPs
increases.
The poor performance of the post-sisVIVE estimators under Scenario 3 is surprising because, superficially at least,
these require only that less than half of the SNPs are invalid. We investigate this further by rerunning the simulations for
Scenario 3 but, when using a two-sample strategy, took the true causal effects 𝛽 j of the SNPs on the exposure to be known
to us for the pleiotropic SNPs rather than observed association bj = 𝛽 j + 𝜃j. The results (not presented) show that the bias,
MSE, and coverage of the sisVIVE-based approaches are similar to those under Scenarios 1 and 2; the same is also true
for MR-Median. This indicates that indirect pleiotropy and the failure of InSIDE have, contrary to theory, a detrimental
effect on these methods' performance.
One possible explanation for this is set out by Windmeijer et al.21 Their proposition 2 contains conditions under which
sisVIVE will not satisfy the “irrepresentable condition” of Zou22 and, hence, cannot be consistent. Crudely put, this con-
dition states that sisVIVE will only be consistent if the strength of the invalid-IV SNPs is greater than those of the valid-IV
ones. This is a possible explanation for the poor performance of sisVIVE in our simulations because our scenario 3 simu-
lations do not satisfy it. However, using corollary 1,21 we set up a new version of our third scenario in which InSIDE fails
but proposition 2 is satisfied; the new design and results are presented in the Supplementary Information: the design is
described in Section S2.2, and the results for 10, 20, and 30 invalid-IV SNPs respectively presented in Tables S12, S13, and
S14. It can be seen from these results that sisVIVE performs as badly as it did when the irrepresentable condition fails, so
we conclude that failure of the irrepresentable condition does not explain our results.
We instead argue that sisVIVE's poor performance is because the consistency criterion (defined in theorem 1)1, which
underpins the identification sisVIVE, cannot be satisfied if indirect pleiotropy leads to failure of the InSIDE condition.
In short, even were the identity of the valid-IV and invalid-IV SNPs known, identification would not be possible because
the effects of direct pleiotropy—and hence, the combined pleiotropic effects—would be confounded with the invalid-IV
SNPs' causal effects on the exposure, so that the consistency criterion would not hold. This result also explains why the
performance of sisVIVE improved in the hypothetical situation, explored above, where 𝛽 j (the causal effect of SNP on
exposure) were known, because this identifies the combined pleiotropic effect. We provide a more detailed argument in
Section S2.3 in the Supplementary Information.
6 DISCUSSION
Our investigation has revealed that, while it outperforms the alternative approacheswe considered, sisVIVEperformswell
in terms ofmean square error but performs particularly poorly if the InSIDE condition fails due to the presence of indirect
pleiotropy. This is despite these scenarios apparently satisfying the sufficient condition that more than 50% of the SNPs
are valid IVs. We argue that this is due to indirect pleiotropy leading to nonidentification and failure of the consistency
criterion of Kang et al. The conclusion from our data analysis, which indicates the true causal effect of BMI could be
underestimated by as much as a factor of five, is thus dependent on an assumption that there is no indirect pleiotropy
throughwhich the SNPs are related to the confounders. In general, such an occurrence cannot be ruled out because genes
are determined at conception, and confounders determined at any point up to the time at which an individual's exposure
is determined. The exception to this would be if there was strong scientific evidence that the phenotypical trait of each
SNP was functionally related to the exposure of interest.
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The performance of sisVIVE in scenarios where InSIDE holds and there is no indirect pleiotropy is more encour-
aging, but more generally, we would recommend that MR studies should be based on a sensitivity analysis involving
robust MR-Egger and “valid IV” methods to capture whether differences between the estimates point to the presence
of pleiotropic SNPs. We would also concur with others who have suggest using unweighted polygenic risk scores or a
two-sample strategy or both.31-33 For a one-sample strategy, it appears that imprecision in the estimatedweights of an IPRS,
while improving efficiency, can lead to substantial bias.While SPRSs performwell here, it is important to note that, in fur-
ther simulations, we found (results not shown) that severe bias was introduced if the effect-allele coding of the SNPs led
to 𝛽𝑗 (or 𝛽𝑗) being positive when true 𝛽 j would have led us to code it the other way; such “flip flopping” is possible,34 even
in the absence of population stratification, but remains a potential source of bias for SPRS despite its being discounted
elsewhere (eg, see page 1883 in the work of Burgess et al).35 The LIML or CUE estimators would, however, be unaffected
by flip-flopping and, unlike 2SLS, not subject to large biases.
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